Camlin Fine Sciences Limited

CAMLINFINE

INE052I01032

Specialty Chemicals

Market Closed - Bombay S.E. Other stock markets 03:30:48 28/05/2024 pm IST			5-day change	1st Jan Change
94.65 ^INR	-2.27%		-5.21%	-30.33%

21/05	Transcript : Camlin Fine Sciences Limited, Q4 2024 Earnings Call, May 21, 2024
20/05	Camlin Fine Sciences Limited Reports Earnings Results for the Full Year Ended March 31, 2024	CI

Camlin Fine Sciences Limited Approves Appointment of Anagha S. Dandekar as Additional Director on the Board

August 28, 2017 at 04:29 pm IST

Camlin Fine Sciences Limited at its board meeting held on August 28, 2017 approved appointment of Ms. Anagha S. Dandekar as Additional Director on the Board of the company.

Latest news about Camlin Fine Sciences Limited

Transcript : Camlin Fine Sciences Limited, Q4 2024 Earnings Call, May 21, 2024	21/05
Camlin Fine Sciences Limited Reports Earnings Results for the Full Year Ended March 31, 2024	20/05	CI
Camlin Fine Sciences Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	20/05	CI
Transcript : Camlin Fine Sciences Limited, Q3 2024 Earnings Call, Feb 09, 2024	09/02
Camlin Fine Sciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	09/02	CI
Transcript : Camlin Fine Sciences Limited, Q2 2024 Earnings Call, Nov 06, 2023	06/11
Camlin Fine Sciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	06/11	CI
Camlin Fine Sciences Limited Appoints Nilesh Jadhav as Chief Operating Officer	06/11	CI
Transcript : Camlin Fine Sciences Limited - Shareholder/Analyst Call	18/23/18
Camlin Fine Sciences Arm Extends Closure of Diphenol Plant in Italy	15/23/15	MT
Infinity Direct Holdings and Infinity Direct Holdings Sidecar I completed the acquisition of 9.7% stake in Camlin Fine Sciences Limited for INR 2.7 billion.	31/23/31	CI
Camlin Fine Sciences Unit Shuts Diphenol Plant in Europe	16/23/16	MT
Camlin Fine Sciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	11/23/11	CI
Univar Solutions Named Authorized Distributor for Camlin Fine Sciences' Aroma Ingredients in US, Canada	29/23/29	MT
Camlin Fine Sciences Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	22/23/22	CI
Camlin Fine Sciences Limited Announces Mr. Sarvjit Bedi Resigns as Non-Executive Director	19/23/19	CI
Infinity Direct Holdings and Infinity Direct Holdings Sidecar I made an offer to acquire 26% stake in Camlin Fine Sciences Limited for INR 7.1 billion.	17/23/17	CI
Camlin Fine Sciences Limited Announces the Resignation of Thomas Videbæk as Non-Executive Independent Director, Effective February 23, 2023	20/23/20	CI
Transcript : Camlin Fine Sciences Limited, Q3 2023 Earnings Call, Feb 14, 2023	14/23/14
Camlin Fine Sciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	13/23/13	CI
Camlin Fine Sciences Begins Commercial Production at New Unit in Gujarat, India	23/23/23	MT
Transcript : Camlin Fine Sciences Limited, Q2 2023 Earnings Call, Nov 12, 2022	12/22/12
Camlin Fine Sciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	12/22/12	CI
Transcript : Camlin Fine Sciences Limited, Q1 2023 Earnings Call, Aug 12, 2022	12/22/12
Camlin Fine Sciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	12/22/12	CI

Chart Camlin Fine Sciences Limited

Duration

Period

More charts

Camlin Fine Sciences Limited is an India-based company, which is engaged in research, development, manufacturing and marketing of specialty chemicals, ingredients, and additive blends. The Company is a provider of diverse advanced antioxidants and shelf-life extensions, aroma ingredients, performance chemical products and related solutions for food, animal nutrition, pet food, pharmaceutical and petrochemical industries globally. Its products include TBHQ, Catechol, BHA, 4-Tertiary Butyl Catechol, Xtendra, Butylated Hydroxy Toluene, Guaiacol, Para DiMethoxy Benzene, NaSure, MEHQ, Ascorbyl Palmitate, and HQEE. The Company manufactures specialty chemicals that can be categorized into shelf-life solutions, performance chemicals, aroma ingredients and health and wellness. Its products are used in varied industries, such as human food, animal feed, pet food, agrochemicals, petrochemicals, pharmaceuticals, nutraceuticals, flavors and fragrances and health care.

Sector

Specialty Chemicals

Calendar

31/07/2024 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Ratings for Camlin Fine Sciences Limited

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

94.65 INR

Average target price

110 INR

Spread / Average Target

+16.22%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Specialty Chemicals

	1st Jan change	Capi.
CAMLIN FINE SCIENCES LIMITED	-30.33%	20Cr
SIKA AG	+0.88%	5TCr
GIVAUDAN SA	+21.10%	4.29TCr
FUJIFILM HOLDINGS CORPORATION	+27.82%	2.73TCr
EMS-CHEMIE HOLDING AG	+9.54%	1.93TCr
CELANESE CORPORATION	-1.91%	1.67TCr
SYMRISE AG	+7.54%	1.61TCr
POSCO FUTURE M CO., LTD.	-25.63%	1.56TCr
ALBEMARLE CORPORATION	-11.09%	1.5TCr
SOCIEDAD QUÍMICA Y MINERA DE CHILE S.A.	-17.00%	1.41TCr

Other Specialty Chemicals